Then, when they do, and invest "hundreds of millions of dollars running Phase 3 trials enrolling over 43,000 participants based on FDA guidance..." to ge a new product approved, they get zero consideration.
Why would the executives not look at this and say "why should we remain based in the US at all?", and just move headquarters to a more business-friendly country?
Sure, the US is a big market, but if one cannot get anything close to a fair treatment of your products, you have no ability to work in that market anyway.
We have a true kakistocracy, a government by the worst, most corrupt, and least qualified.